High parathormone levels are associated with adverse cardiovascular events in coronary patients with high fibroblast growth factor-23 - Gutierrez, C; Acena, A; Pello, A; Martinez-Milla, J; Gonzalez-Lorenzo; Tarin, N; Cristobal, C; Huelmos, A; Lopez-Castillo, M; Alonsos, J; Gonzalez-Parra, E; Egido, J; et al. (European Heart Journal, 2020)